12:00 AM
Mar 12, 2001
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

ExonHit Therapeutics S.A.,

Paris, France

Technology: Differential Analysis of Transcripts with Alternative Splicing (DATAS)

Disease focus: NA


Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >